Biomedicine

Today, millions of people are finding relief using medical cannabis treatments. Evidence-Based-Medicine (EBM), shows that cannabis and its derivatives are safe and effective treatment agents for common symptoms of pain, spasticity, vomiting, and nausea.

Preclinical and observational research is showing many promising therapeutic applications of cannabis, however, clinical evidence is lacking.  There are high hopes that the anti-tumor, immune-enhancing, pro-homeostatic properties of cannabis that have been demonstrated in preclinical trials, will successfully translate to curative treatments of a wide range of human medical conditions including: 

  • Cancers

  • HIV/AIDS

  • Hepatitis C

  • Multiple sclerosis

  • Alzheimer's disease and other neurodegenerative disorders

  • Epilepsy and seizure disorders

  • Glaucoma

  • Post-traumatic stress disorder (PTSD) and other mental illnesses

  • Idiopathic inflammatory gastrointestinal disorders (e.g. Crohn’s disease)

  • Chronic wound treatment 

True Potential of cannabis treatments

Conventional pharmaceutical development requires isolation or synthesis of new compounds and observing their effects in vitro and in vivo before their safety profile and therapeutic benefits can be studied in humans. Researchers have already observed the therapeutic effect and safety profile of cannabis in small clinical studies of diverse patient groups. Cannabis and cannabinoid treatments require further clinical evidence to refine the therapeutic applicability of cannabis-based medicines.

 

Interest in cannabis and cannabinoid research spans across academia, private institutes, governments, private industry, medical professionals, patient advocacy organizations, health service providers and not-for-profit organization, among others. Unleashing the true potential of cannabis and cannabinoid treatments requires a cross-disciplinary approach that captures the current knowledge base across the fields of biomedical research, social science, life science, and policy research. This cross-disciplinary approach will identify and solve barriers to progress, and create a platform for shared knowledge. 

For further information, please see:

Review of Contemporary Knowledge of the Treatment Effects of Cannabis and Related Products, and Its Outlook

 

 


Newsletter

By clicking sign up I give me consent to ICCI to process my personal data for the purpose of obtaining newsletters. More information can be found HERE.

ICCI webinar "How to Register Medicinal Products in the EU" with Dr. Martin Votava 25. 9. 2019

Cookies help us deliver our services and provide personalized experiences. By using this website, you agree to our use of cookies and privacy policy. More info